In a recently conducted Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study, researchers discovered that intensive blood sugar control appears to reduce the risk of eye disease progression in people with type 2 diabetes, and who are likewise at risk of diabetic retinopathy.
In the new study, participants on intensive therapy had average hemoglobin A1C levels and the researchers found that the therapy had cut retinopathy progression by about one-third and posed a possible treatment with continuous use of fenofibrate.
Previous studies have reported similar findings, the researchers said.
The study was scheduled to be presented in New Orleans. Findings presented at meetings are generally viewed as preliminary until published in a peer-reviewed journal.
Source: Agencies
